11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
In early December, the United States District Court for the Southern District of New York denied, in...
Read More >
The year-end federal spending bill, the Further Consolidated Appropriations Act, 2020 (“FCAA”), wa...
Read More >
On October 11, 2019, Vice Chancellor Kathaleen S. McCormick of the Delaware Court of Chancery dismis...
Read More >
Most Employers Need to Make Plan Document and Administrative Changes - In late 2018, the Internal R...
Read More >
The Alabama Department of Environmental Management (“ADEM”) and National Carbon Capture Center (“...
Read More >
If you want to avoid potential liability from a former employee, remember a key maxim: Stick to your...
Read More >